前往主要內容區間
掛號頁面

血液暨腫瘤科

  • 蘇迺文醫師相片

    蘇迺文

    主治醫師

    血液暨腫瘤科 :
    台北門診掛號  淡水門診掛號
    信望愛特別門診 :
    台北門診掛號  

    蘇迺文醫師本頁二維碼

  • 現職

      馬偕紀念醫院 細胞治療及微體醫學科主任
      馬偕紀念醫院 血液腫瘤科 資深主治醫師

    主要學歷

      國立陽明大學 傳統醫藥研究所博士
      國立陽明大學 醫學士

    主要經歷

      腫瘤內科專科醫師
      血液病專科醫師
      內科專科醫師

    其他相關

      <學會會員>
      台灣內科醫學會
      中華民國癌症醫學會
      中華民國血液病學會
      台灣安寧緩和醫學會
      <證書>
      醫師證書
      內科專科醫師證書
      中華民國血液病專科醫師證書
      中華民國腫瘤內科專科醫師證書

主治項目或專長

頭頸部癌、肺癌、乳癌 、胃腸道癌症,泌尿道癌症及其它各類惡性腫瘤、血液病、貧血、淋巴瘤。


論文研究

  1. Su CW, Lee JC, Chang YF, Su NW*, Lee PH, Dai KY, Tai HC, Leu YS, Chen YJ. Delta-volume radiomics of induction chemotherapy to predict outcome of subsequent chemoradiotherapy for locaaly advanced hypopharyngeal cancer. Tumori. 2021 Aug 21.

  2. Su NW*, Wu SH, Chi CW, Tsai TH, Chen YJ. Cordycepin, isolated from medicinal fungus Cordyceps sinensis, enhances radiosensitivity of oral cancer associated with modulation of DNA damage repair. Food Chem Toxicol. 2019; 124: 400-410.

  3. Chang CC, Chou KF, Wu CW, Su NW*, Peng CL, Su YW, Chang J, Ho AS, Ln HC, Chen CG, Yang BL, Chang YC, Chiang YW, Lim KH, Chang YF. EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumor spheres as a therapeutic target against EGFR-positive non-small cell lung cancer. Lung Cancer. 2018; 116: 80-89.

  4. Chiang YH, Chang YC, Lin HC, Huang L, Cheng CC, Wang WT, Cheng HI, Su NW*, Chen CG, Lin J, Chang YF, Chang MC, Hsieh RK, Chou WC, Lim KH, Kuo YY. Germline variations at JAK2, TERT, HBS1L-MYB, MECOM and the risk of myeloproliferative neoplasms in Taiwanese population. Oncotarget. 2017; 8: 76204-76213.

  5. Lim KH, Chen CG, Chang YC, Chiang YH, Kao CW, Wang WT, Chang CY, Huang L, Lin CS, Cheng CC, Cheng HI, Su NW*, Lin J, Chang YF, Chang MC, Hsieh RK, Lin HC, Kuo YY. Increased B cell activation is present in JAK2V617F-mutated, CARL-mutated and triple-negative essential thrombocythemia. Oncotarget. 2017; 16: 32476-32491.

  6. Su NW*, Wu SH, Chi CW, Liu CJ, Tsai TH, Chen YJ. Metronomic cordycepin therapy prolongs survival of oral cancer-bearing mice and inhibits epithelial-mesenchymal transition. Molecules. 2017; 22(4).

  7. Lim KH, Chang YC, Gon-Shen Chen C, Lin HC, Wang WT, Chiang YH, Cheng HI, Su NW*, Lin J, Chang YF, Chang MC, Hsieh RK, Kuo YY, Chou WC. Frequent CARL exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis. Blood Cancer J. 2015; 20: e295.

  8. Lim KH, Lin HC, Chen CG, Wang WT, Chang YC, Chiang YH, Lin CS, Su NW*, Su YW, Lin J, Chang YF, Chang MC, Hsieh RK, Kuo YY, Chou WC. Rapid and sensitive detection of CARL exon 9 mutations using high-resolution melting analysis. Clin Chim Acta 2015;440:133-139.

  9. Su NW*, Liu CJ, Leu YS, Lee JC, Chen YJ, Chang YF. Prolonged radiation time and low nadir hemoglobin during postoperative concurrent chemoradiotherapy are both poor prognostic factors with synergistic effect on locally advanced head and neck cancer patients. Onco Targets Ther 2015; 28 :251-258.

  10. Su NW*, Leu YS, Lee JC, Liu CJ, Cheng CY, Lin JS, Chen YJ, Chen CK, Fang IC, Hsieh RK, Chang YF. EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy. Onco Targets Ther 2014; 28:2179-2204.

  11. Su NW*, Leu YS, Lee JC, Chen YJ, Chen HW, Liu CJ, Chang YF. Comparison of the efficacy and toxicity of two dose levels of cisplatin/5-fluorouracil as the chemoradiotherapy regimen for the treatment of locally advanced squamous cell carcinoma. Acta Otolaryngol 2011; 131:1333-1340.

  12. Su NW*, Chen CK, Chen GS, Hsieh RK, Chang MC. A case of tuberculosis-induced hemophagocytic lymphohistiocytosis in a patient under hemodialysis. In t J Hematol 2009; 89:298-301.

  13. Tsai KH, Lai MY, Shen SH, Yang AH, Su NW*, Ng YY. Bilateral xanthogranulomatous pyelonephritis. J Chin Med Assoc. 2008; 71:310-314.